ArticleInternational journal of women's health2026
Effect of Disodium Etidronate on Bone Mineral Density in Postmenopausal Women: A Six-Month Prospective Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postmenopausal osteoporosis, characterized by rapid bone loss, raises fracture risk. Bisphosphonates are standard treatments. This study evaluates the 6-month efficacy of Disodium Etidronate, a first-generation bisphosphonate with a distinct mechanism, on bone mineral density (BMD) at the hip and lumbar spine in postmenopausal women, an area with limited data. Objective: This study aimed to assess the effect of a 6-month Disodium Etidronate course on BMD in postmenopausal women. Methods: A prospective cohort study enrolled 70 postmenopausal women. Participants received 60 mg of Disodium Etidronate orally once daily for six months. BMD at the femoral neck, trochanter, total hip, and lumbar spine (L1-L4) was measured via dual-energy X-ray absorptiometry (DXA) at baseline and post-treatment. Changes in BMD, site-specific differences, and influencing factors (age, BMI, calcium intake, exercise) were analyzed. Results: After treatment, BMD increased significantly at all sites (all P<0.001): femoral neck (0.70±0.15 to 0.75±0.13 g/cm Conclusion: A six-month Disodium Etidronate regimen effectively increases BMD in postmenopausal women, with greater efficacy in the lumbar spine. Efficacy is influenced by age, BMI, calcium intake, and exercise. The treatment demonstrates good safety and tolerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.